Quick Answer
Dyne Therapeutics, Inc. reported Total Assets of $1.19 billion for fiscal year 2025.
Dyne Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.19B | +71.7% |
| 2024 | $691.23M | +318.7% |
| 2023 | $165.08M | -46.1% |
| 2022 | $306.32M | -28.0% |
| 2021 | $425.66M | +20.5% |
| 2020 | $353.33M | +2049.8% |
| 2019 | $16.44M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $867.06M | +12.8% | +18.9% |
| June 30, 2025 | $728.99M | -11.7% | +1.1% |
| March 31, 2025 | $721.07M | +38.1% | +4.3% |
| December 31, 2024 | $691.23M | +318.7% | -10.1% |
| September 30, 2024 | $768.84M | +274.6% | -6.9% |
| June 30, 2024 | $825.88M | +228.5% | +58.1% |
| March 31, 2024 | $522.28M | +80.9% | +216.4% |
| December 31, 2023 | $165.08M | -46.1% | -19.6% |
- Dyne Therapeutics, Inc. showed an increase of +71.7% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Dyne Therapeutics, Inc.’s total assets has grown by 7121.7% (from $16.44 million to $1.19 billion).
- The most recent figure is from Dyne Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: